Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of De-escalation of Axillary Surgery in ycN0 Breast Cancer Patients Post NAC for cN2, cN3 Disease: Evaluating the Concordance Between ypN Status From TAD and ALND

NCT07856160 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT07856160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07856160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of De-escalation of Axillary Surgery in ycN0 Breast Cancer Patients Post NAC for cN2, cN3 Disease: Evaluating the Concordance Between ypN Status From TAD and ALND
Lead sponsor
University of Nebraska
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
November 15, 2031
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer by ajcc v8 anatomic stage